These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2568032)

  • 21. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
    J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
    Dumont JE; Miot F; Erneux C; Couchie D; Cochaux P; Gervy-Decoster C; Van Sande J; Wells JN
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():325-36. PubMed ID: 6202125
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development during ontogenesis of the hormone reactivity of metabolic enzyme systems and cyclic nucleotide function].
    Pertseva MN
    Usp Sovrem Biol; 1978; 86(2):177-91. PubMed ID: 31741
    [No Abstract]   [Full Text] [Related]  

  • 26. Species-specific aggregation factor in sponges. VII. Its effect on cyclic amp and cyclic gmp metabolism in cells of Geodia cydonium.
    Müller WE; Müller I; Zahn RK; Kurelec B
    Cell Tissue Kinet; 1978 Jan; 11(1):23-32. PubMed ID: 23901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of cortisol on adenylate cyclase and 3',5'-AMP phosphodiesterase activity and 3',5'-AMP concentration in tissues and biological fluids in experimental atherosclerosis].
    Speranskaia NV; Ozerova IN; Shcherbakova IA; Gerasimova EN
    Vopr Med Khim; 1977; (6):777-82. PubMed ID: 202090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The newborn mouse as a model for study of the effects of hormonal steroids in the young.
    Kohrman AF
    Pediatrics; 1978 Dec; 62(6 Pt 2):1143-50. PubMed ID: 31596
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic-GMP-regulated enzymes and their possible physiological functions.
    Walter U
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of interferon on the cAMP system in cells].
    Balandin IG; Krispin TI; Kalmakhelidze KA; Itkes AV; Solov'eva MF
    Mol Gen Mikrobiol Virusol; 1988 Oct; (10):40-4. PubMed ID: 2852775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
    Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
    Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase dysfunction, cyclic GMP accumulation, and visual cell degeneration in early-onset inherited blindness.
    Lolley RN; Lee RH
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():315-27. PubMed ID: 6145326
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB; Krzanowski JJ; Goldman AL; Szentivanyi A
    Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP, adenylate cyclase and cyclic AMP-phosphodiesterase activities in diabetic rat adipocytes.
    Chiappe de Cingolani GE
    Acta Physiol Pharmacol Latinoam; 1986; 36(1):39-46. PubMed ID: 3020875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alterations in the cyclase system of skeletal muscles and in the content of cyclic nucleotides in blood plasma of rats after the administration of caffeine].
    Gorbachevskaia LV
    Vopr Med Khim; 1983; 29(4):47-51. PubMed ID: 6137907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [1 of the possible causes of an increase in acid hydrolase activity in homogenates of heart muscle following myocardial infarct].
    Strezhneva TIu; Skorik VI; Safonova ES; Korovkin BF
    Vopr Med Khim; 1977; 23(2):251-4. PubMed ID: 196409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.